Richland County Safety Council BWC Pharmacy Program Drug Utilization Management Outcomes John Hanna, R.Ph. BWC, Pharmacy Director 7/13/2015BWC Pharmacy.

Slides:



Advertisements
Similar presentations
Common/shared responsibilities between jobs.
Advertisements

What You Wanted to Know About Formularies Emmanuelle Mirsakov Pharm.D. Candidate 2007 USC School Of Pharmacy.
Management of Drug Formulary Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 06/16/06.
Pharmacy Benefit Managers (PBMs)
DoD Pharmacoeconomic Center The Impact of Sole Provider Program (SPP) / Warrior in Transition (WT) CHCS Drug Entries 1.
Greater Care. Zero Waste. PROPRIETARY AND CONFIDENTIAL © 2011 Express Scripts, Inc. All Rights Reserved. 1 Greater Care. Zero Waste. PROPRIETARY AND CONFIDENTIAL.
New York State Medicaid Fee-for-Service (FFS) Pharmacy Prior Authorization Programs Presented by: Magellan Medicaid Administration, Inc. & New York State.
Challenges of Serving Low-income Medicare Beneficiaries: Impact of Cost Sharing Cindy Parks Thomas Brandeis University Schneider Institute for Health Policy.
Improved Retrospective Drug Utilization Review for Potential Opioid Overutilizers — Results from the Pilot CMS 2012 Medicare Advantage & Prescription Drug.
Arkansas Children’s Behavioral Health Care Commission AR DHS Division of Medical Services Pharmacy Program Laurence H. Miller, M.D., Senior Psychiatrist.
Pharmacy Program Initiatives Threshold, Mandatory Generic, Maximum Allowable Cost (MAC) Javier Menendez, RPh Pharmacy Manager Department of Medical Assistance.
Drug Utilization Review (DUR)
Innovations: Using a Clinical Pharmacist as a Vehicle for Successful P4P Outcomes Lisa Meland, B.S., PharmD. Helen Pervanas, R.Ph. WellPoint-WellPoint.
1 District of Columbia Medical Assistance Administration Expedited Prior Authorization Pharmacy Guidance NOTE: As of October 1, 2008, the Medical Assistance.
Workers’ Compensation Pharmacy Benefit Management Brian Carpenter, RPh VP, Program Management May 2009.
Controlled Substance Prescribing Trends and Physician and Pharmacy Utilization Patterns: Epidemiological Analysis of the Maine Prescription Monitoring.
Omnibus Budget Reconciliation Act (OBRA-90) Goal To save money.
Promoting high quality, cost effective drug therapy throughout the Military Health System MTF Prescription Restriction Program MTF Prescription Restriction.
Plan Year. 2 WHAT’S NOT CHANGING FOR 2014  Premiums will remain the SAME  First Choice providers and Generic Medications are STILL NO COST TO.
Meeting the Medication Needs of Iowans: the IowaCare Pilot Pharmaceutical Program and UIHC Medication Assistance Center Lisa Mascardo, PharmD Assistant.
Prescription Module in AxiUm (for prescription and OTC medications) at the USC School of Dentistry 2005 Marina Lazzara-Jimenez, RDH Director of Quality.
340B Implementation: An Opportunity for Improved Health Outcomes in Communities Todd D. Sorensen, Pharm.D. Associate Professor University of Minnesota.
Presented by: Keenan & Associates Debra L. Yorba, Sr. Vice President February 22, 2014 License Plan Design Sub-Committee Recommendations KPPC/ESI.
Mental Health Clinical Pharmacy Services and Pilot at Regions Hospital
Midwest Business Group on Health National Employer Survey on Biologics/Specialty Pharmacy August 2011.
Centralized Non-Formulary Processing: Implementation of a CPRS “Reminder Dialog Template” Note to Request Restricted Drugs and Utilization of VISN 17 PBM.
URx : Rethinking our Rx program: A New Strategic Approach.
Presentation to Oregon Self-Insurers Association Controlling Medical Severity through Modeling Risk Identification July 12, 2012.
© 2014 Helios 1 Managing Pharmacy Care New Hampshire Commission to Recommend Reforms to Reduce Workers’ Compensation Medical Costs.
AN EVOLVING SUCCESS STORY THE INTEGRATION OF CARE COORDINATION :
Lower workers’ compensation costs? Presented by: Diana Blaha.
State of New Hampshire Pharmacy Benefit Changes Effective November 1, 2011 Presented By: Melisa Briggs.
ADAP Solutions for the future Glen Pietrandoni, R.Ph., AAHIVP, Sr Director, Virology Adam Reno, Sr. Strategic Account Manager, State Governments ©2013.
Florida Agency for Health Care Administration Florida Center for Health Information and Policy Analysis Florida Public Health Association - Medical Director’s.
1 Governor’s Office of Health Policy and Finance MaineCare Pharmacy Initiatives.
Department of Health and Vanderbilt University Chronic Pain Guidelines Symposium Elizabeth Lund, Executive Director, Board of Nursing Linda Johnson, APN.
Rx Abuse in Workers’ Compensation
ASPECTS AFFECTING THE HOSPITAL OPERATION Financial Financial Operational Operational Administrative Administrative Clinical Clinical Safety Safety.
Avalere Health LLC | The intersection of business strategy and public policy Formulary Design: Balancing Cost and Access November 1, 2005 Presented By:
Medicaid Fee-for-Service: Prior Authorization Criteria & the Role of the DUR Board Charles Agte, Pharmacy Administrator Health Care Services June 19, 2013.
MaineCare Policies to Prevent Pharmaceutical Waste Jennifer Palow Pharmacy Director.
1  Expert pharmacy benefit management (PBM) consulting team  In-house pharmacists, PBM and Medicare Part D experts  Former C-level PBM executives averaging.
American Society of Consultant Pharmacists America’s Senior Care Pharmacists ® Effects of Medicare Part D on Dual Eligibles in LTC Settings Thomas R. Clark,
MEDICATION MANAGEMENT P&T COMMITTEE AND FORMULARY MANAGEMENT EMTENAN ALHARBI, Msc CLINICAL PHARMACIST.
Evaluation of Virginia’s Preferred Drug List: 4th Quarter Report Policy and Research Division November 2, 2004Department of Medical Assistance Services.
Drug Formulary Development & Management
Technology, Information Systems and Reporting in Pharmacy Benefit Management Presentation Developed for the Academy of Managed Care Pharmacy Updated: February.
What is Managed Care Pharmacy? Developed by AMCP Membership Committee
Pharmacy Benefit Management (PBM) 101
Managed Care Career Path for Student Pharmacists Presentation Developed for the Academy of Managed Care Pharmacy Updated February 2015.
Pharmacist Opportunities Within a Pharmacy Benefit Manager Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2015.
ERX Enhancement Project Presentation for the EDM Forum June 7, 2014 San Diego, CA.
Medication Therapy Management Part D Programs Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2014.
Travis County HRMD FY 2012 Benefits Work Session Employee Benefits Committee HRMD Staff.
Pharmacy Benefit Design Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2016.
MEDICATION USE IN RURAL AMERICA ASSOCIATION UPDATES National Community Pharmacists Association Tina Schlecht, PharmD, MBA Director, Pharmacy Affairs.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
Oregon Prescription Drug Monitoring Program
Pharmacy Provider Meeting March 15, 2017
THE OPIOID CRISIS Mississippi Board of Nursing
Effectiveness of Care Measures
The Basics of Pharmacy Benefit Management (PBM)
Specialty Pharmacy Management
Sandeep Wadhwa, MD, MBA, Vice President, Care Management Services
Therapeutic Drug Management Quality Project
Primum non nocere Olabisi Oshikanlu M.D., F.A.A.P
Third National Medicare Congress
Unsustainable Trend Commercial Plan members averaging 232,964 per quarter. (Stats do not include our 73,000 Medicare retirees) Plan received critical Board.
Employees Retirement System of Texas (ERS) Changing the Script
Pharmacy Benefit Manager
Presentation transcript:

Richland County Safety Council BWC Pharmacy Program Drug Utilization Management Outcomes John Hanna, R.Ph. BWC, Pharmacy Director 7/13/2015BWC Pharmacy Program Overview1 May 21, 2015

Discussion Overview  The BWC Pharmacy Program & Mission  How the Mission is Accomplished  Impact on Drug Utilization  Impact on Opioids –  Mission Focus Going Forward 7/13/2015BWC Pharmacy Program Overview2

The BWC Pharmacy Program 2014 vs ,022 Injured Workers received an Rx (-26%) 990,369 Prescriptions covered (-36%) $113.4M total prescription cost (-16%) – Average Unit cost/Rx = $ (+8.2%) – Average Rx Cost/Injured Worker=$2, (+13.7%) Generic Dispensing Rate = 83.4% (+4.8% vs ‘13) – Each 1% Increase in GDR = $3.35M cost savings 7/13/2015BWC Pharmacy Program Overview3

The Pharmacy Program Mission Manage drug utilization to ensure coverage for necessary medications to allow proper care of injured workers in a fiscally responsible manner. 7/13/2015BWC Pharmacy Program Overview4

The Pharmacy Tools 7/13/2015BWC Pharmacy Program Overview5 Relatedness Drugs & Prior Authorization Requirements Drug Utilization Reviews Formulary

The BWC Formulary (OAC ) Implemented Sept. 1, 2011 Revisions – 2011 thru 2014 o Limited coverage of muscle relaxants o Deleted coverage of some IR & SR opiates o Introduced tiered coverage for all SR opiates o Designated a class generic for anti-ulcer agents

Formulary Revisions 2011 thru /13/2015BWC Pharmacy Program Overview7 o Set a maximum daily dose for both anti- anxiety and butalbital containing drugs o Limited coverage to 4 hypnotics o Limited coverage of anti-psychotics o Limited coverage of testosterone agents o 2014 o Added coverage for 7 new drugs o Deleted coverage for 2 drugs

7/13/2015BWC Pharmacy Program Overview8 Formulary Impact: Drug Utilization 2014 vs 2010 o 24% fewer Injured workers received opioids o Opioid prescriptions (-38%) o 48% fewer Injured workers received muscle relaxants o Muscle relaxant prescriptions (-72%) o 79% fewer injured workers received anti-ulcer drugs o Anti-Ulcer prescriptions (-83%)

7/13/2015BWC Pharmacy Program Overview9 Formulary Impact: Drug Costs 2014 vs 2010 Total drug costs: -$22.8 million (-16.8%) o Opioids: -$19.9 million (-36%) o Muscle relaxants: -$2.8 million (-78%) o Anti-ulcer drugs: -$6.4 million (-95%)

Automated Rx Edits: Relatedness List Drugs 7/13/2015BWC Pharmacy Program Overview10  In 2014 Automated Edits  Applied in the pharmacy on all Rxs  Stopped initial coverage of 235,000 Rxs  Relatedness List Edits  May require a PA  Apply to 373 of 405 drug classes  Matches drug indication & allowed conditions  3900 PAs processed by the PBM Pharmacists  4400 PAs processed by BWC staff

7/13/2015BWC Pharmacy Program Overview11 Automated Rx Edits: Formulary & Special Claim Edits  Rxs for certain formulary drugs require a PA  SR Opioids, Muscle Relaxants, Testosterone  Some require an allowance – Fentora, Lidoderm,Suboxone  Special Claims Edits  Medical Only Claims  All require a PA after 60days from DOI  Claims with no prescriptions for 270 days  Require a PA for any prescription

7/13/2015BWC Pharmacy Program Overview12 Drug Utilization Reviews  2014 BWC-MCO Workgroup Recommendation  Transition this activity to the MCOs  DUR workgroup began work in June  New process developed  Pilot of new process began in November 2014  Transition to all MCO’s 7/1/2014  4192 DURs performed by BWC/MCOs in 2010  2664 DURs performed by MCOs in 2014

7/13/2015BWC Pharmacy Program Overview13 Injured Workers Receiving Medications 2001 to 2014

7/13/2015BWC Pharmacy Program Overview14 Injured Workers Receiving Opioids

7/13/2015BWC Pharmacy Program Overview15 Opioid Utilization

7/13/2015BWC Pharmacy Program Overview16 Opioid Utilization

BWC Opiate Utilization 2010 vs /13/2015BWC Pharmacy Program Overview17 o BWC’s opiate dependency guideline: 60mg MED/Day for 60 days o In fourth quarter ,689 injured workers received this dose of opiates 13% of all injured workers receiving medications in 2010 were opiate dependent. 17% of of injured workers receiving opioids o In fourth quarter 2014: 5,469 injured workers met it ; 11% of all injured workers receiving medications. 16% of injured workers receiving opioids

7/13/2015BWC Pharmacy Program Overview18 Top 10 Highest Opiate Prescribers 2010 vs High dose opiate prescribers - 4th quarter 2010 Prescriber Patients with total Mg MED/day > 399 Patients with total Mg MED/day Patients with total Mg MED/day Patients with total Mg MED/day > 999 Dr. A Dr. B Dr. C Dr. D*13112 Dr. E*12615 Dr. F12102 Dr. J*11551 Dr. H99 Dr. I871 Dr. J*88 High dose opiate prescribers - 4th quarter 2014 Prescriber Patients with total Mg MED/day > 399 Patients with total Mg MED/day Patients with total Mg MED/day Patients with total Mg MED/day > 999 Dr. B13841 Dr. K**11911 Dr. L11 Dr. M761 Dr. N6411 Dr. O66 Dr. P651 Dr. Q651 Dr. A**5131 Dr. W55

7/13/2015BWC Pharmacy Program Overview19 Acute to Chronic Opioid Use In New Claims Date of Injury (DOI) 2011 vs IWs with DOIs in 2011Totals Percent of 2011 totalIWs with DOIs in 2013Totals Percent of 2013 total 2011 vs Percent change IWs that received RX prior to July 20128,448 IWs that received RX Prior to , % IWs with "acute" opiate script (RX with 28 days)4,75456% IWs with acute opiate script ( RX with 28 days)3,45258%-27% IWs with ongoing opiate script (RX after 84 days)4,48353% IWs with ongoing opiate script (RX after 84 days)2,755 46% -39% IWs with acute and ongoing opiate Rx after July 20121,53118% IWs with acute and ongoing opiate Rx after July %-44%

7/13/2015BWC Pharmacy Program Overview vs 2014 Opioid Dependence (Injured Workers Above 60mg MED/Day)

7/13/2015BWC Pharmacy Program Overview21 Opioid Use By Age of Injured Worker

7/13/2015BWC Pharmacy Program Overview22 Percentage of Opioid Use By Injured Worker Age Q vs Q4-2014

7/13/2015BWC Pharmacy Program Overview23 Going Forward o Implement an automated process to identify high risk medication regimens and trigger direct clinical staff contact with the prescriber. o Establish an opioid prescribing rule based on best clinical practices for both prescribing as well as discontinuing these drugs. o Initiate a retail pharmacy based medication therapy management program to coordinate medications in high risk claims.

Thank You! Questions?